Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 based on Infection Type
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 based on Vaccine Type
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 based on End-Users
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 based on Region
North America coronavirus vaccine market revenue (US$ Million) by Country, 2020 to 2030
Europe coronavirus vaccine market revenue (US$ Million) by Country, 2020 to 2030
Asia Pacific coronavirus vaccine market revenue (US$ Million) by Country, 2020 to 2030
Latin America coronavirus vaccine market revenue (US$ Million) by Country, 2020 to 2030
Middle East & Africa coronavirus vaccine market revenue (US$ Million) by Country, 2020 to 2030
Competitive Landscape
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Coronavirus Vaccine Market Snapshot
Chapter 4. Global Coronavirus Vaccine Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Clinical Trial/Pipeline Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Major Investment, Partnerships and Collaborations in COVID 19 Research
Chapter 5. Market Segmentation 1: By Infection Type, Estimates & Trend Analysis
5.1. By Infection Type, & Market Share, 2020 & 2030
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Infection Type:
5.2.1. HCoV-229E
5.2.2. HCoV-OC43
5.2.3. SARS-CoV
5.2.4. New Haven CoV
5.2.5. HKU1-CoV
5.2.6. MERS-CoV
Chapter 6. Market Segmentation 2: By Vaccine Type Estimates & Trend Analysis
6.1. By Vaccine Type & Market Share, 2020 & 2030
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Vaccine Type:
6.2.1. Protein subunit
6.2.2. Viral Vector (non-replicating)
6.2.3. DNA
6.2.4. Inactivated Virus
6.2.5. RNA
6.2.6. Viral Vector (replicating)
6.2.7. Virus Like Particle
6.2.8. Others
Chapter 7. Market Segmentation 3: By End-Users Estimates & Trend Analysis
7.1. By End-Users & Market Share, 2020& 2030
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By End-Users:
7.2.1. Hospitals
7.2.2. Clinics
7.2.3. Research Institutes
7.2.4. Others
Chapter 8. Coronavirus Vaccine Market Segmentation 3: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Coronavirus Vaccine Market revenue (US$ Million) estimates and forecasts By Infection Type, 2020-2030
8.1.2. North America Coronavirus Vaccine Market revenue (US$ Million) estimates and forecasts By Vaccine Type, 2020-2030
8.1.3. North America Coronavirus Vaccine Market revenue (US$ Million) estimates and forecasts By End-Users, 2020-2030
8.1.4. North America Coronavirus Vaccine Market revenue (US$ Million) estimates and forecasts by country, 2020-2030
8.2. Europe
8.2.1. Europe Coronavirus Vaccine Market revenue (US$ Million) By Infection Type, 2020-2030
8.2.2. Europe Coronavirus Vaccine Market revenue (US$ Million) By Vaccine Type, 2020-2030
8.2.3. Europe Coronavirus Vaccine Market revenue (US$ Million) By End-Users, 2020-2030
8.2.4. Europe Coronavirus Vaccine Market revenue (US$ Million) by country, 2020-2030
8.3. Asia Pacific
8.3.1. Asia Pacific Coronavirus Vaccine Market revenue (US$ Million) By Infection Type, 2020-2030
8.3.2. Asia Pacific Coronavirus Vaccine Market revenue (US$ Million) By Vaccine Type, 2020-2030
8.3.3. Asia Pacific Coronavirus Vaccine Market revenue (US$ Million) By End-Users, 2020-2030
8.3.4. Asia Pacific Coronavirus Vaccine Market revenue (US$ Million) by country, 2020-2030
8.4. Latin America
8.4.1. Latin America Coronavirus Vaccine Market revenue (US$ Million) By Infection Type, (US$ Million)
8.4.2. Latin America Coronavirus Vaccine Market revenue (US$ Million) By Vaccine Type, (US$ Million)
8.4.3. Latin America Coronavirus Vaccine Market revenue (US$ Million) By End-Users, (US$ Million)
8.4.4. Latin America Coronavirus Vaccine Market revenue (US$ Million) by country, (US$ Million) 2020-2030
8.5. Middle East & Africa
8.5.1. Middle East & Africa Coronavirus Vaccine Market revenue (US$ Million) By Infection Type, (US$ Million)
8.5.2. Middle East & Africa Coronavirus Vaccine Market revenue (US$ Million) By Vaccine Type, (US$ Million)
8.5.3. Middle East & Africa Coronavirus Vaccine Market revenue (US$ Million) By End-Users, (US$ Million)
8.5.4. Middle East & Africa Coronavirus Vaccine Market revenue (US$ Million) by country, (US$ Million) 2020-2030
Chapter 9. Competitive Landscape
9.1. Company Profiles
9.1.1. I-Mab Biopharma
9.1.2. Medicago
9.1.3. Airway Therapeutics
9.1.4. Tiziana Life Sciences
9.1.5. Inovio Pharmaceuticals
9.1.6. Novavax, Inc
9.1.7. Moderna
9.1.8. AstraZeneca
9.1.9. Pfizer
9.1.10. Johnson &Johnson
9.1.11. GlaxoSmithKline
9.1.12. Bharath Biotech
9.1.13. Serum Institute of India
9.1.14. Sinopharm
9.1.15. AnGes
9.1.16. AIVITABiomedical
9.1.17. CanSinoBio
9.1.18. eubiologics
9.1.19. Genexine
9.1.20. GreenLight Bioscience
9.1.21. Gennova
9.1.22. Heat Biologics
9.1.23. INOVIO
9.1.24. IIBR
9.1.25. medicago
9.1.26. Symvivo
9.1.27. Valneva
9.1.28. Zydus Cadila
9.1.29. CODAGENIX Inc.
9.1.30. Other Prominent Player
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.